Skip to main content

3 Result(s)

within Stina Söderlund Remove this filter Medicine/Public Health, general Remove this filter

and

  1. Article

    Open Access

    Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

    Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele… in Leukemia (2024)

    Download PDF (333 KB) View Article

  2. Article

    Open Access

    Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial

    Tyrosine kinase inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML) has become part of routine care for patients with a sustained deep molecular response (DMR). Approximately 50% experience a mol...

    Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele… in Leukemia (2024)

    Download PDF (1064 KB) View Article

  3. Article

    Open Access

    Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR—final report from AFTER-SKI

    Johan Richter, Anna Lübking, Stina Söderlund, Kourosh Lotfi, Berit Markevärn… in Leukemia (2021)

    Download PDF (297 KB) View Article